Key points are not available for this paper at this time.
Our studies suggest that CaMKII is a molecular signal that couples increased reactive oxygen species with AF and that therapeutic strategies to decrease oxidized CaMKII may prevent or reduce AF.
Purohit et al. (Fri,) studied this question.